Cycling Intervention on Symptoms of Patients With Knee Osteoarthritis

April 6, 2020 updated by: Tanner Thorsen, The University of Tennessee, Knoxville
This study is designed to determine the effect of a cycling training program which modulates frontal and sagittal plane knee joint loading with graded increases of Q-Factor and cycling workrate in persons with symptomatic knee osteoarthritis.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The knee joint is one of the most common joints affected by osteoarthritis, and knee osteoarthritis is primarily observed in the medial compartment. This is in part attributable to the increased load experienced by the medial compartment during level walking. Patients with symptomatic knee osteoarthritis exhibit altered gait mechanics; namely a reduced loading response knee extension moment and an increased internal knee abduction moment. As a surrogate measure for medial compartment joint loading, loading response knee abduction moment in level walking has been shown to increase with the severity of knee osteoarthritis.

Recent gait modification research has shown that increased step-width decreases peak Knee abduction moment for persons with knee osteoarthritis. The inter-pedal width of a bicycle or cycle ergometer, known as Q-Factor, is analogous in cycling to step-width in gait. In contrast to gait, increased Q-Factor has been shown to increase the knee abduction moment during stationary cycling. Modulating sagittal and frontal plane loading of the knee in a graded manner during cycling may promote healthy adaptation to muscle weakness and pain. This adaptation may be manifest through restoration of altered knee joint biomechanics (knee extension moment, knee abduction moment), which, in turn, may also provide benefit to gait mechanics.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Knoxville, Tennessee, United States, 37996
        • Recruiting
        • Biomechanics/Sports Medicine Lab
        • Contact:
          • Songning Zhang, PhD
          • Phone Number: 865-974-4716
          • Email: szhang@utk.edu
        • Contact:
        • Principal Investigator:
          • Tanner Thorsen, MS
        • Principal Investigator:
          • Songning Zhang, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

46 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and Women between the ages of 50 and 75 years old.
  • Diagnosed with medial compartment tibiofemoral osteoarthritis in one of their knees.
  • Be able to walk unaided for at least 25 consecutive minutes.
  • Present with knee pain for at least 6 months occurring on a majority of the days in the month, or on most days (more than or equal to 4 of 7 days in a week) in one or both knees for at least 4 months.
  • Osteophytes on knee x-rays.
  • Grade 2 or higher out of a maximum of 4 on a modified Kellgren/Lawrence grade on the knee radiograph.

Exclusion Criteria:

  • Initial Visual Analog Scale pain scores greater than 7.
  • Diagnosed osteoarthritis of ankles, hips, or symptomatic osteoarthritis of the spine.
  • Arthroplasty of any other lower extremity joint.
  • BMI value greater than 40 kg/m2.
  • Any major lower extremity injury in the past 6 months.
  • Systemic Inflammatory Arthritis.
  • Systemic Pain Conditions.
  • Neurological Conditions that impact gait or cycling.
  • Pregnant or Nursing Women.
  • Major cardiovascular disease with an exercise limitation prescribed by a physician.
  • Steroid injection at the knee within the previous 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Q-Factor Intervention
Participants will progress through three increasing Q-Factors for each cycling workrate; Q-Factor 1 (Q1, 192mm), Q2 (234mm), Q3 (276mm). After completing bouts of all three Q-Factors for a given workrate, workrate will be increased by 20 Watts and bouts at each Q-Factor will be repeated.
The intervention period will consist of 12 training sessions across four consecutive weeks, with three training sessions held per week. If pain is not increased or reduced and Rating of Perceived Exertion is ≤12, the participant will progress to the next bout. If pain is increased from the pre-bout pain score, participants will repeat the bout, at the same workrate and Q-Factor settings. Following this fashion, participants will progress through three increasing Q-Factors for each given workrate; Q-Factor 1 (Q1, 192mm), Q2 (234mm), Q3 (276mm). After completing bouts of all three Q-Factors for a given workrate, workrate will be increased by 20 Watts and bouts at each Q-Factor will be repeated. For each training session, participants will complete bouts of cycling until 1) the maximum number of bouts (4 bouts) has been accomplished, 2) self-reported Rating of Perceived Exertion >12, indicating a transition to moderate physical activity, or 3) self-reported pain >5.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Abduction Moment - Cycling
Time Frame: Baseline, 1 month, 2 month
Change in Knee Extension Moment during cycling.
Baseline, 1 month, 2 month
Knee Abduction Moment - Gait
Time Frame: Baseline, 1 month, 2 month
Change in Knee Extension Moment during gait.
Baseline, 1 month, 2 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Pain
Time Frame: Immediately following exercise (walking and cycling).
Self-Reported pain intensity during gait and cycling reported on a scale from 1-10 with higher scores reflecting more pain.
Immediately following exercise (walking and cycling).
Knee Extension Moment - Cycling
Time Frame: Baseline, 1 month, 2 month
Change in Knee Extension Moment during cycling
Baseline, 1 month, 2 month
Knee Extension Moment - Gait
Time Frame: Baseline, 1 month, 2 month
Change in Knee Extension Moment during Gait
Baseline, 1 month, 2 month
Knee Injury and Osteoarthritis Outcome Score
Time Frame: Baseline, 1 month, 2 month
Change in Knee Injury and Osteoarthritis Outcome Score reported on a scale from 0 to 100, with 0 representing extreme problems and 100 representing no problems.
Baseline, 1 month, 2 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tanner Thorsen, MS, University of Tennessee, Knoxville

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 17, 2019

Primary Completion (Anticipated)

May 31, 2021

Study Completion (Anticipated)

May 31, 2021

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

October 23, 2019

First Posted (Actual)

October 25, 2019

Study Record Updates

Last Update Posted (Actual)

April 7, 2020

Last Update Submitted That Met QC Criteria

April 6, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • UTK IRB-19-05254-XP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Q-Factor Intervention

Subscribe